Tag: FDA approval
Biosimilars vs. Generics: How to Choose the Right Treatment Option
Learn the key differences between biosimilars and generic drugs. Discover how they compare in cost, safety, and regulation to help you choose the right affordable treatment option.
30-Month Stay: How Patent Litigation Delays Generic Drug Approval
The 30-month stay under the Hatch-Waxman Act delays generic drug approval by freezing FDA approval during patent litigation. Learn how this legal tool is used - and abused - to block cheaper medications, costing billions annually.
